Brickell Biotech Company

Brickell Biotech is focused on the acquisition, development, and commercialization of drug therapies for the treatment of skin diseases.
Technology: Biotechnology, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: Miami, Florida, United States
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 3
Total Funding: 33464587
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-07-19
Last Funding Type: Post-IPO Equity

Visit Website
info@brickellbio.com
Register and Claim Ownership